Table 4.
Relative abundance at the genus level in patients with dCCA and the onset of common bile duct stones.
| Genus | mean (group_T) | sd (group_T) | mean (group_C) | sd (group_C) | p value |
|---|---|---|---|---|---|
| Staphylococcus | 0.1065 | 0.2852 | 0.0320 | 0.1476 | 0.0002 |
| Okibacterium | 0.0055 | 0.0051 | 0.0011 | 0.0048 | 0.0004 |
| Corynebacterium | 0.0043 | 0.0071 | 0.0002 | 0.0004 | 0.0009 |
| Sphingomonas | 0.0047 | 0.0035 | 0.0006 | 0.0014 | 0.0018 |
| Stenotrophomonas | 0.0119 | 0.0110 | 0.0016 | 0.0042 | 0.0021 |
| Acidovorax | 0.0008 | 0.0009 | 0.0002 | 0.0006 | 0.0026 |
| Gemmiger | 0.0049 | 0.0071 | 0.0004 | 0.0010 | 0.0027 |
| Providencia | 0.0030 | 0.0067 | 0.0009 | 0.0041 | 0.0027 |
| Comamonas | 0.0071 | 0.0079 | 0.0006 | 0.0022 | 0.0028 |
| Methylobacterium | 0.0011 | 0.0009 | 0.0003 | 0.0005 | 0.0029 |
The dCCA group (Tumor group, T), the new onset of CBD stones group (CBD stones group, C), and recurrent CBD stones group (Post-ERCP CBD stones group, P) denoted as “Group T”, “Group C”, and “Group P”, respectively, in the table.